|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 122, Issue 12 3829-3837, Copyright © 1996 by Company of Biologists
JOURNAL ARTICLES |
E Kukk, A Lymboussaki, S Taira, A Kaipainen, M Jeltsch, V Joukov and K Alitalo
Molecular/Cancer Biology Laboratory, Haartman Institute, University of Helsinki, Finland.
The vascular endothelial growth factor family has recently been expanded by the isolation of two new VEGF-related factors, VEGF-B and VEGF-C. The physiological functions of these factors are largely unknown. Here we report the cloning and characterization of mouse VEGF-C, which is produced as a disulfide-linked dimer of 415 amino acid residue polypeptides, sharing an 85% identity with the human VEGF-C amino acid sequence. The recombinant mouse VEGF-C protein was secreted from transfected cells as VEGFR-3 (Flt4) binding polypeptides of 30-32x10(3) Mr and 22-23x10(3) Mr which preferentially stimulated the autophosphorylation of VEGFR-3 in comparison with VEGFR-2 (KDR). In in situ hybridization, mouse VEGF-C mRNA expression was detected in mesenchymal cells of postimplantation mouse embryos, particularly in the regions where the lymphatic vessels undergo sprouting from embryonic veins, such as the perimetanephric, axillary and jugular regions. In addition, the developing mesenterium, which is rich in lymphatic vessels, showed strong VEGF-C expression. VEGF-C was also highly expressed in adult mouse lung, heart and kidney, where VEGFR-3 was also prominent. The pattern of expression of VEGF-C in relation to its major receptor VEGFR-3 during the sprouting of the lymphatic endothelium in embryos suggests a paracrine mode of action and that one of the functions of VEGF-C may be in the regulation of angiogenesis of the lymphatic vasculature.
This article has been cited by other articles:
![]() |
T. Sasaki, T. Nakamura, R. B. Rebhun, H. Cheng, K. S. Hale, R. Z. Tsan, I. J. Fidler, and R. R. Langley Modification of the Primary Tumor Microenvironment by Transforming Growth Factor {alpha}-Epidermal Growth Factor Receptor Signaling Promotes Metastasis in an Orthotopic Colon Cancer Model Am. J. Pathol., July 1, 2008; 173(1): 205 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sivakumar, N. Sharma-Walia, H. Raghu, M. V. Veettil, S. Sadagopan, V. Bottero, L. Varga, R. Levine, and B. Chandran Kaposi's Sarcoma-Associated Herpesvirus Induces Sustained Levels of Vascular Endothelial Growth Factors A and C Early during In Vitro Infection of Human Microvascular Dermal Endothelial Cells: Biological Implications J. Virol., February 15, 2008; 82(4): 1759 - 1776. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Sundar and T. S. Ganesan Role of Lymphangiogenesis in Cancer J. Clin. Oncol., September 20, 2007; 25(27): 4298 - 4307. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Gaspar, L. Li, A. M. Kapoun, S. Medicherla, M. Reddy, G. Li, G. O'Young, D. Quon, M. Henson, D. L. Damm, et al. Inhibition of Transforming Growth Factor beta Signaling Reduces Pancreatic Adenocarcinoma Growth and Invasiveness Mol. Pharmacol., July 1, 2007; 72(1): 152 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shayan, M. G. Achen, and S. A. Stacker Lymphatic vessels in cancer metastasis: bridging the gaps Carcinogenesis, September 1, 2006; 27(9): 1729 - 1738. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Rutkowski, K. C. Boardman, and M. A. Swartz Characterization of lymphangiogenesis in a model of adult skin regeneration Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1402 - H1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Favier, A. Alam, P. Barron, J. Bonnin, P. Laboudie, P. Fons, M. Mandron, J.-P. Herault, G. Neufeld, P. Savi, et al. Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration Blood, August 15, 2006; 108(4): 1243 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Janer, P. Lassus, C. Haglund, K. Paavonen, K. Alitalo, and S. Andersson Pulmonary Vascular Endothelial Growth Factor-C in Development and Lung Injury in Preterm Infants Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 326 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Foster, S. C. Satchell, J. Seckley, M. S. Emmett, K. Joory, C. Y. Xing, M. A. Saleem, P. W. Mathieson, D. O. Bates, and S. J. Harper VEGF-C promotes survival in podocytes Am J Physiol Renal Physiol, July 1, 2006; 291(1): F196 - F207. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Levine, A. Tulpule, D. I. Quinn, G. Gorospe III, D. L. Smith, L. Hornor, W. D. Boswell, B. M. Espina, S. G. Groshen, R. Masood, et al. Phase I Study of Antisense Oligonucleotide Against Vascular Endothelial Growth Factor: Decrease in Plasma Vascular Endothelial Growth Factor With Potential Clinical Efficacy J. Clin. Oncol., April 10, 2006; 24(11): 1712 - 1719. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Sidle, J. Maddalozzo, J. D. Meier, M. Cornwell, V. Stellmach, and S. E. Crawford Altered Pigment Epithelium-Derived Factor and Vascular Endothelial Growth Factor Levels in Lymphangioma Pathogenesis and Clinical Recurrence Arch Otolaryngol Head Neck Surg, November 1, 2005; 131(11): 990 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.E. Ferguson III, R. W. Kelley, and C. Patterson Mechanisms of Endothelial Differentiation in Embryonic Vasculogenesis Arterioscler. Thromb. Vasc. Biol., November 1, 2005; 25(11): 2246 - 2254. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Baldwin, M. M. Halford, S. Roufail, R. A. Williams, M. L. Hibbs, D. Grail, H. Kubo, S. A. Stacker, and M. G. Achen Vascular Endothelial Growth Factor D Is Dispensable for Development of the Lymphatic System Mol. Cell. Biol., March 15, 2005; 25(6): 2441 - 2449. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tammela, B. Enholm, K. Alitalo, and K. Paavonen The biology of vascular endothelial growth factors Cardiovasc Res, February 15, 2005; 65(3): 550 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sipos, W. Klapper, M.-L. Kruse, H. Kalthoff, D. Kerjaschki, and G. Kloppel Expression of Lymphangiogenic Factors and Evidence of Intratumoral Lymphangiogenesis in Pancreatic Endocrine Tumors Am. J. Pathol., October 1, 2004; 165(4): 1187 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukasawa and M. Korc Vascular Endothelial Growth Factor-Trap Suppresses Tumorigenicity of Multiple Pancreatic Cancer Cell Lines Clin. Cancer Res., May 15, 2004; 10(10): 3327 - 3332. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Dana Corneal Antigen-Presenting Cells: Diversity, Plasticity, and Disguise The Cogan Lecture Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 722 - 727. [Full Text] [PDF] |
||||
![]() |
F Belgore, A Blann, D Neil, A S Ahmed, and G Y H Lip Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteries J. Clin. Pathol., March 1, 2004; 57(3): 266 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Homer, M. G. Prentice, L. Cawkwell, M. Birchall, J. Greenman, and N. D. Stafford Angiogenesis and the Expression of Vascular Endothelial Growth Factors A and C in Squamous Cell Carcinoma of the Piriform Fossa Arch Otolaryngol Head Neck Surg, October 1, 2003; 129(10): 1110 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hamrah, L. Chen, Q. Zhang, and M. R. Dana Novel Expression of Vascular Endothelial Growth Factor Receptor (VEGFR)-3 and VEGF-C on Corneal Dendritic Cells Am. J. Pathol., July 1, 2003; 163(1): 57 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsumura, M. Hirashima, M. Ogawa, H. Kubo, H. Hisatsune, N. Kondo, S. Nishikawa, T. Chiba, and S.-I. Nishikawa Modulation of VEGFR-2-mediated endothelial-cell activity by VEGF-C/VEGFR-3 Blood, February 15, 2003; 101(4): 1367 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. STACKER, M. E. BALDWIN, and M. G. ACHEN The role of tumor lymphangiogenesis in metastatic spread FASEB J, July 1, 2002; 16(9): 922 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jussila and K. Alitalo Vascular Growth Factors and Lymphangiogenesis Physiol Rev, July 1, 2002; 82(3): 673 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. He, K.-i. Kozaki, T. Karpanen, K. Koshikawa, S. Yla-Herttuala, T. Takahashi, and K. Alitalo Suppression of Tumor Lymphangiogenesis and Lymph Node Metastasis by Blocking Vascular Endothelial Growth Factor Receptor 3 Signaling J Natl Cancer Inst, June 5, 2002; 94(11): 819 - 825. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. V. Byzova, C. K. Goldman, J. Jankau, J. Chen, G. Cabrera, M. G. Achen, S. A. Stacker, K. A. Carnevale, M. Siemionow, S. R. Deitcher, et al. Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo Blood, May 29, 2002; 99(12): 4434 - 4442. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Oliver and M. Detmar The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature Genes & Dev., April 1, 2002; 16(7): 773 - 783. [Full Text] [PDF] |
||||
![]() |
S. Dias, M. Choy, K. Alitalo, and S. Rafii Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy Blood, March 15, 2002; 99(6): 2179 - 2184. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsumoto and L. Claesson-Welsh VEGF Receptor Signal Transduction Sci. Signal., December 11, 2001; 2001(112): re21 - re21. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Wang, X.-F. Zhang, and J. E. Groopman Stimulation of beta 1 Integrin Induces Tyrosine Phosphorylation of Vascular Endothelial Growth Factor Receptor-3 and Modulates Cell Migration J. Biol. Chem., November 2, 2001; 276(45): 41950 - 41957. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P Erickson, S. L Dagenais, M. S Caulder, C. A Downs, G. Herman, M. C Jones, W. S Kerstjens-Frederikse, A. C Lidral, M. McDonald, C. C Nelson, et al. Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations J. Med. Genet., November 1, 2001; 38(11): 761 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Clarijs, L. Schalkwijk, D. J. Ruiter, and R. M. W. de Waal Lack of Lymphangiogenesis Despite Coexpression of VEGF-C and Its Receptor Flt-4 in Uveal Melanoma Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1422 - 1428. [Abstract] [Full Text] |
||||
![]() |
X. F. Li, D. S. Charnock-Jones, E. Zhang, S. Hiby, S. Malik, K. Day, D. Licence, J. M. Bowen, L. Gardner, A. King, et al. Angiogenic Growth Factor Messenger Ribonucleic Acids in Uterine Natural Killer Cells J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1823 - 1834. [Abstract] [Full Text] |
||||
![]() |
K. ILJIN, M. J. KARKKAINEN, E. C. LAWRENCE, M. A. KIMAK, M. UUTELA, J. TAIPALE KATRI PAJUSOLA LEENA ALHONEN, M. HALMEKYTO, D. N. FINEGOLD, R. E. FERRELL, and K. ALITALO VEGFR3 gene structure, regulatory region, and sequence polymorphisms FASEB J, April 1, 2001; 15(6): 1028 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Karpanen, M. Egeblad, M. J. Karkkainen, H. Kubo, S. Ylä-Herttuala, M. Jäättelä, and K. Alitalo Vascular Endothelial Growth Factor C Promotes Tumor Lymphangiogenesis and Intralymphatic Tumor Growth Cancer Res., March 1, 2001; 61(5): 1786 - 1790. [Abstract] [Full Text] |
||||
![]() |
W. J. Huss, C. F. Hanrahan, R. J. Barrios, J. W. Simons, and N. M. Greenberg Angiogenesis and Prostate Cancer: Identification of A Molecular Progression Switch Cancer Res., March 1, 2001; 61(6): 2736 - 2743. [Abstract] [Full Text] |
||||
![]() |
M. S. Pepper Lymphangiogenesis and Tumor Metastasis: Myth or Reality? Clin. Cancer Res., March 1, 2001; 7(3): 462 - 468. [Abstract] [Full Text] |
||||
![]() |
I. Zachary and G. Gliki Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family Cardiovasc Res, February 16, 2001; 49(3): 568 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Robinson and S. Stringer The splice variants of vascular endothelial growth factor (VEGF) and their receptors J. Cell Sci., January 3, 2001; 114(5): 853 - 865. [Abstract] [PDF] |
||||
![]() |
R. J. Klasa, A. F. List, and B. D. Cheson Rational Approaches to Design of Therapeutics Targeting Molecular Markers Hematology, January 1, 2001; 2001(1): 443 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hamada, Y. Oike, N. Takakura, Y. Ito, L. Jussila, D. J. Dumont, K. Alitalo, and T. Suda VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis Blood, December 1, 2000; 96(12): 3793 - 3800. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Gunningham, M. J. Currie, C. Han, B. A. Robinson, P. A. E. Scott, A. L. Harris, and S. B. Fox The Short Form of the Alternatively Spliced flt-4 but not Its Ligand Vascular Endothelial Growth Factor C Is Related to Lymph Node Metastasis in Human Breast Cancers Clin. Cancer Res., November 1, 2000; 6(11): 4278 - 4286. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. PARTANEN, J. AROLA, A. SAARISTO, L. JUSSILA, A. ORA, M. MIETTINEN, S. A. STACKER, M. G. ACHEN, and K. ALITALO VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues FASEB J, October 1, 2000; 14(13): 2087 - 2096. [Abstract] [Full Text] |
||||
![]() |
A. Saaristo, T. A. Partanen, J. Arola, L. Jussila, M. Hytonen, A. Makitie, S. Vento, A. Kaipainen, H. Malmberg, and K. Alitalo Vascular Endothelial Growth Factor-C and Its Receptor VEGFR-3 in the Nasal Mucosa and in Nasopharyngeal Tumors Am. J. Pathol., July 1, 2000; 157(1): 7 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Niki, S. Iba, M. Tokunou, T. Yamada, Y. Matsuno, and S. Hirohashi Expression of Vascular Endothelial Growth Factors A, B, C, and D and Their Relationships to Lymph Node Status in Lung Adenocarcinoma Clin. Cancer Res., June 1, 2000; 6(6): 2431 - 2439. [Abstract] [Full Text] |
||||
![]() |
M. M. L. Deckers, M. Karperien, C. van der Bent, T. Yamashita, S. E. Papapoulos, and C. W. G. M. Lowik Expression of Vascular Endothelial Growth Factors and Their Receptors during Osteoblast Differentiation Endocrinology, May 1, 2000; 141(5): 1667 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Nathanson, R. J. Zarbo, D. L. Wachna, C. A. Spence, T. A. Andrzejewski, and J. Abrams Microvessels That Predict Axillary Lymph Node Metastases in Patients With Breast Cancer Arch Surg, May 1, 2000; 135(5): 586 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Paavonen, P. Puolakkainen, L. Jussila, T. Jahkola, and K. Alitalo Vascular Endothelial Growth Factor Receptor-3 in Lymphangiogenesis in Wound Healing Am. J. Pathol., May 1, 2000; 156(5): 1499 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Wood, G. Bold, E. Buchdunger, R. Cozens, S. Ferrari, J. Frei, F. Hofmann, J. Mestan, H. Mett, T. OReilly, et al. PTK787/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration Cancer Res., April 1, 2000; 60(8): 2178 - 2189. [Abstract] [Full Text] |
||||
![]() |
V. L. Bautch, S. D. Redick, A. Scalia, M. Harmaty, P. Carmeliet, and R. Rapoport Characterization of the vasculogenic block in the absence of vascular endothelial growth factor-A Blood, March 15, 2000; 95(6): 1979 - 1987. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lymboussaki, B. Olofsson, U. Eriksson, and K. Alitalo Vascular Endothelial Growth Factor (VEGF) and VEGF-C Show Overlapping Binding Sites in Embryonic Endothelia and Distinct Sites in Differentiated Adult Endothelia Circ. Res., November 26, 1999; 85(11): 992 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marchio, L. Primo, M. Pagano, G. Palestro, A. Albini, T. Veikkola, I. Cascone, K. Alitalo, and F. Bussolino Vascular Endothelial Growth Factor-C Stimulates the Migration and Proliferation of Kaposi's Sarcoma Cells J. Biol. Chem., September 24, 1999; 274(39): 27617 - 27622. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Marconcini, S. Marchio, L. Morbidelli, E. Cartocci, A. Albini, M. Ziche, F. Bussolino, and S. Oliviero c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro PNAS, August 17, 1999; 96(17): 9671 - 9676. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R Kersten, P. S Pagel, W. M Chilian, and D. C Warltier Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia Cardiovasc Res, July 1, 1999; 43(1): 44 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. Gale and G. D. Yancopoulos Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, Angiopoietins, and ephrins in vascular development Genes & Dev., May 1, 1999; 13(9): 1055 - 1066. [Full Text] |
||||
![]() |
N. Dupin, C. Fisher, P. Kellam, S. Ariad, M. Tulliez, N. Franck, E. van Marck, D. Salmon, I. Gorin, J.-P. Escande, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma PNAS, April 13, 1999; 96(8): 4546 - 4551. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Maddalozzo, C. A. Hughes, L. Huang, Y. Mu, J. Ludemann, and S. Crawford High Angiogenic Activity in Cells Isolated From Cystic Hygroma: Role of bFGF Arch Otolaryngol Head Neck Surg, January 1, 1999; 125(1): 45 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cao, P. Linden, J. Farnebo, R. Cao, A. Eriksson, V. Kumar, J.-H. Qi, L. Claesson-Welsh, and K. Alitalo Vascular endothelial growth factor C induces angiogenesis in vivo PNAS, November 24, 1998; 95(24): 14389 - 14394. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ogawa, A. Oku, A. Sawano, S. Yamaguchi, Y. Yazaki, and M. Shibuya A Novel Type of Vascular Endothelial Growth Factor, VEGF-E (NZ-7 VEGF), Preferentially Utilizes KDR/Flk-1 Receptor and Carries a Potent Mitotic Activity without Heparin-binding Domain J. Biol. Chem., November 20, 1998; 273(47): 31273 - 31282. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Dumont, L. Jussila, J. Taipale, A. Lymboussaki, T. Mustonen, K. Pajusola, M. Breitman, and K. Alitalo Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3 Science, October 30, 1998; 282(5390): 946 - 949. [Abstract] [Full Text] |
||||
![]() |
B. Witzenbichler, T. Asahara, T. Murohara, M. Silver, I. Spyridopoulos, M. Magner, N. Principe, M. Kearney, J.-S. Hu, and J. M. Isner Vascular Endothelial Growth Factor-C (VEGF-C/VEGF-2) Promotes Angiogenesis in the Setting of Tissue Ischemia Am. J. Pathol., August 1, 1998; 153(2): 381 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
|